T
T2 BIOSYSTMS INC
NASDAQ: TTOO (T2 Biosystems, Inc.)
Last update: 2 hours ago0.000
0.00 (-60.00%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | T2 Biosystems, Inc. | Mixed | Mixed |
AIStockmoo Score
| Value 40% | -5.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -5.0 |
| Timing 40% | 0.0 |
| AI Technical info | NA |
| Technical Oscillators info | 0.0 |
| Technical Moving Averages info | 0.0 |
| Smart Money 20% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.13 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | NA |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | NA |
| Final Score | -2.26 |
Select this tab to load the latest available analysis.
|
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company’s products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Value |
| % Held by Insiders | 8.07% |
| % Held by Institutions | 38.15% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Horizon Financial Services, Llc | 31 Dec 2025 | 9 |
| Union Bancaire Privee, Ubp Sa | 31 Dec 2025 | 1 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |